
FDA Approves Genentech's Susvimo for Diabetic Retinopathy
Genentech's ranibizumab injection (Susvimo) has received FDA approval for the treatment of diabetic retinopathy. The continuous delivery system is intended for patients who have previously responded to anti-VEGF injections. “The approval of Susvimo for …